(Q45401707)

14 December 2017

Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database (English)

1 reference

14 December 2017

0 references

1 reference

5

Yi-Ming A Chen

1 reference

14 December 2017

Jialun Zhou

1

1 reference

14 December 2017

Gregory J Dore

2

1 reference

14 December 2017

Fujie Zhang

3

1 reference

14 December 2017

Poh Lian Lim

4

1 reference

14 December 2017

TREAT Asia HIV Observational Database

6

1 reference

14 December 2017

20 July 2007

1 reference

Journal of Gastroenterology and Hepatology

14 December 2017

1 reference

14 December 2017

22

1 reference

14 December 2017

9

1 reference

14 December 2017

1510-1518

1 reference

Epidemiology of viral hepatitis and HIV co-infection

14 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

The prevalence of hepatitis B and C in HIV-positive Greek patients: relationship to survival of deceased AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

Hepatitis C and progression of HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

The TREAT Asia HIV Observational Database: baseline and retrospective data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

Effectiveness of generic fixed-dose combinations of highly active antiretroviral therapy for treatment of HIV infection in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping Due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05062.X

10.1111/J.1440-1746.2007.05062.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference